LFG
IONS icon

Larson Financial Group’s Ionis Pharmaceuticals IONS Stock Holding History

Larson Financial Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Sell
3,000
-31
-1% -$2.33K 0.01% 778
2026
Q1 		$228K Buy
3,031
+691
+30% +$54.5K 0.01% 679
2025
Q4 		$185K Buy
2,340
+1,230
+111% +$92.6K 0.01% 719
2025
Q3 		$72.6K Buy
1,110
+83
+8% +$4.05K ﹤0.01% 1023
2025
Q2 		$40.6K Buy
1,027
+684
+199% +$22.4K ﹤0.01% 1152
2025
Q1 		$10.3K Buy
343
+325
+1,806% +$10.6K ﹤0.01% 1628
2024
Q4 		$629 Hold
18
– – ﹤0.01% 2143
2024
Q3 		$721 Hold
18
– – ﹤0.01% 2053
2024
Q2 		$858 Buy
+18
New +$738 ﹤0.01% 1738

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Larson Financial Group's IONS Position: Q2 2026 in Review

Larson Financial Group reduced its Ionis Pharmaceuticals (IONS) stake by 1% in Q2 2026, selling an estimated $2.33K and leaving 3,000 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #778.

Larson Financial Group first reported a position in IONS in Q2 2024 and has held it in 9 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Larson Financial Group held 3,000 shares of Ionis Pharmaceuticals worth $238K as of Q2 2026.
  • Larson Financial Group sold 31 Ionis Pharmaceuticals shares in Q2 2026, an estimated $2.33K.
  • Ionis Pharmaceuticals made up 0.01% of Larson Financial Group's portfolio in Q2 2026, its #778 holding.
  • Larson Financial Group first reported a position in Ionis Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.